Altria Group, Inc.
MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/302% above fair value
$77.17−0.86 (-1.10%)
Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%
Altria Oral Tobacco Products by Year
Oral Tobacco Products — Gross Net Revenues Including Excise Taxes ($M) ($M)
Altria Oral Tobacco Products: $2,802M in FY2025, up 0.9% from a year earlier. That is the highest of the 12 years on record here.
Latest, FY2025
2,802
Period ended Dec 31, 2025
Change on a year earlier
+0.9%
2,776 in FY2024
History
12 years
Since FY2014
Sources
11
Documents cited below
Where the FY2025 figure comes from
“|| Net revenues | $ | 706 | $ | 692 | 2.0 | % | $ | 2,802 | $ | 2,776 | 0.9 | %”
Source: Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000007), filed 2026-01-29 ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Altria Oral Tobacco Products ($M), annual FY2014–FY2025 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/oral-net-rev
See every metric in the Altria KPI table. Data updated Nov 2, 2026.